# NM_021930.6(RINT1):c.1105A>C (p.Arg369=)

https://sugi.bio/variant/rint1-p-arg369

## Summary

**RINT1 p.Arg369= (c.1105A>C)** is classified **Likely benign** in RINT1 (ClinVar, Single submitter, 1 submitter; last evaluated 2022-04-19). Absent from gnomAD v4.1.

**At a glance:** Likely benign · review: Single submitter · rsID rs2133400524 · 1 submitter · absent from gnomAD v4.1

## For patients & families {#patients}

This is a change in the RINT1 gene that is classified as likely benign — not considered disease-causing, submitted by 1 submitter.

*Reference information, not medical advice, and not a prediction for any individual. A genetic counselor or clinician can interpret what it means for you and your family.*

**Support & next steps:** [Find a genetic counselor (NSGC)](https://findageneticcounselor.nsgc.org/).

## Identity {#identity}

| Field | Value |
| --- | --- |
| Gene | [RINT1](https://sugi.bio/atlas/gene/RINT1/) |
| Protein change (HGVS p.) | p.Arg369= |
| Coding change (HGVS c.) | c.1105A>C |
| MANE Select transcript | [NM_021930](https://www.ncbi.nlm.nih.gov/nuccore/NM_021930) |
| dbSNP | [rs2133400524](https://www.ncbi.nlm.nih.gov/snp/rs2133400524/) |
| Variant type | single nucleotide variant |
| Location | chr7:105550163-105550163 (GRCh38) |
| ClinVar | [VCV1793497](https://www.ncbi.nlm.nih.gov/clinvar/variation/1793497/) |

**All HGVS expressions:** `NC_000007.13:g.105190610A>C`, `NC_000007.14:g.105550163A>C`, `NG_051951.1:g.23083A>C`, `NM_001346599.2:c.871A>C`, `NM_001346600.2:c.82A>C`, `NM_001346601.2:c.181A>C`, `NM_001346603.2:c.82A>C`, `NM_021930.6:c.1105A>C`, `NR_144478.2:n.1220A>C`

## Computational & population evidence {#evidence}

**Concordance:** Mixed / partial computational evidence (see below).

- **Missense predictors (AlphaMissense/REVEL/SaProt) do not apply** to this variant type — they score amino-acid substitutions only. For non-missense variants the computational signal comes from conservation (below), not from a missing predictor score.
- Conservation: phyloP 2.401, GERP 2.33, phastCons 0.847 — highly conserved position (PP3-type support)
- CADD: **PHRED 12.37**. No single ClinGen-calibrated threshold exists and the expert panels that use CADD disagree — GUCY2D/AIPL1 require ≥ 20.0 for an untranslated-region variant, ABCA4 ≥ 28.1 for a synonymous or indel variant, the Pulmonary Hypertension panel imports Pejaver 2022's missense-calibrated numbers, and the Antibody Deficiencies panel declines CADD entirely for PIK3CD. CADD v1.7 also incorporates Zoonomia phyloP, so it partly re-expresses the conservation above. *Descriptive; no threshold applied.*
- SpliceAI: **below the reporting threshold**. This position is scored for a different substitution (A>T, Δ0.22 donor gain), so this allele was evaluated and its deltas all fell under Δ0.2 — a prediction of no splicing effect for this allele, not a gap in our data. *No ACMG code assigned.*
- Population frequency: **absent from gnomAD v4.1** — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

*Computational predictors are not independent (ClinGen Variant Classification guidance): AlphaMissense (Cheng et al. 2023) carries the ACMG weight for missense and conservation (phyloP/GERP/phastCons) for non-missense; REVEL (Pejaver-2022 calibrated strength bands) and SaProt (Su et al. 2023, structure-aware, ClinVar-independent protein language model, raw LLR) are shown as orthogonal agreement signals, not additive. For frequency, the gnomAD v4.1 grpmax filtering allele frequency (FAF95) is ClinGen's designated BA1/BS1 input (gnomAD v4 guidance v3.0, June 2025); BA1/BS1 thresholds are disease-specific, not a blanket 5%. Predictions, not a clinical determination.*

## Gene constraint & dosage {#gene-context}

**RINT1** population constraint: LOEUF 0.931, pLI 3.8414e-15, missense-Z 0.92023; ClinGen dosage — haploinsufficiency 0/3, triplosensitivity 0/3. *Lower LOEUF and higher pLI indicate a gene that tolerates loss-of-function poorly; ClinGen dosage is the curated haploinsufficiency call.*

Curated gene–disease validity (ClinGen):

- **hereditary breast carcinoma** — Refuted (AD)
- **familial ovarian cancer** — No Known Disease Relationship (AD)

## Protein context {#protein}

Residue **369** lies in the rint1/tip20 domain.

AlphaFold model confidence (whole protein): pLDDT 85.97, 63% of residues very-high.

## What this gene does {#gene-function}

*Describes the biological roles of RINT1 (the gene this variant disrupts) — not effects measured for this specific variant. A damaging variant is expected to affect these functions and pathways; the degree depends on the variant.*


### Pathways affected {#pathways}

RINT1 participates in **1 Reactome pathway** (⚕ = disease pathway):

| Pathway (Reactome) | Evidence |
| --- | --- |
| [COPI-dependent Golgi-to-ER retrograde traffic](https://reactome.org/content/detail/R-HSA-6811434) | other |

### Molecular function & processes (GO — experimentally supported) {#go}

**Biological process:** mitotic G2 DNA damage checkpoint signaling, regulation of ER to Golgi vesicle-mediated transport.

## Clinical significance {#significance}

**Likely benign** — review status Single submitter *(criteria provided, single submitter)*, last evaluated 2022-04-19.

**Submitter consensus:** unanimous (1/1 Likely benign).

### Submitter classifications {#submitters}

| Submitter | Classification | Review | Method | Date |
| --- | --- | --- | --- | --- |
| Ambry Genetics | Likely benign | criteria provided, single submitter | clinical testing | 2022-04-19 |

**Reported phenotype names (ClinVar):** not specified, AllHighlyPenetrant.

## Similar variants {#similar}

Related RINT1 variant pages (same residue, condition, or type): [RINT1 p.Arg369Met](/variant/rint1-p-arg369met), [RINT1 p.Arg369Trp](/variant/rint1-p-arg369trp), [RINT1 c.1107+1G>T](/variant/rint1-c-1107-plus-1g-t), [RINT1 c.1886+5G>A](/variant/rint1-c-1886-plus-5g-a), [RINT1 c.516-3C>T](/variant/rint1-c-516-minus-3c-t), [RINT1 c.840-12T>A](/variant/rint1-c-840-minus-12t-a), [RINT1 c.840-3C>G](/variant/rint1-c-840-minus-3c-g), [RINT1 p.Ala138Thr](/variant/rint1-p-ala138thr).

### Data sources & attribution {#sources}

ClinVar (NCBI — public domain, built 2026-10-14); gnomAD v4.1 (Broad Institute, built 2026-10-14); AlphaMissense (Cheng et al. 2023, © Google DeepMind — CC BY 4.0, built 2026-01-27); REVEL (Ioannidis et al. 2016 — ODbL, built 2026-07-13); SaProt (Su et al. 2023 — MIT, built 2026-10-14); SpliceAI (Illumina — free for non-commercial use, built 2026-10-13); CADD (Rentzsch et al. 2019, University of Washington — free for non-commercial use, built 2026-10-10); Conservation (phyloP/phastCons/GERP) (UCSC hg38 470-way mammal (Hiller Lab) + Ensembl Compara, built 2026-07-12); gnomAD Non-coding Constraint (Gnocchi) (Chen et al. 2024, Broad Institute — CC0, built 2026-10-11); gnomAD Regional Missense Constraint (Broad Institute — CC0, built 2026-10-13); Pangolin (Zeng & Li 2022 — CC BY 4.0, built 2026-10-11); Repeat regions (UCSC — RepeatMasker, TRF, segmental duplications, built 2026-10-11); ClinGen (ClinGen, built 2026-09-22); UniProt (CC BY 4.0); Reactome / GO (CC BY 4.0, built 2026-09-23); MaveDB (per-record license, built 2026-10-11); CIViC (CC0, built 2026-09-22); Orphanet (Orphanet, built 2026-06-12)

*Primary record: NCBI ClinVar (variation 1793497). Classifications reflect these databases as of the page's build date and may change. Free reference use — not medical advice; consult the primary submitters and a clinician.*